CSIMarket

Piedmont Lithium Inc   (PLL)
Other Ticker:  
 
 
Price: $51.7900 $-0.51 -0.975%
Day's High: $54.73 Week Perf: 4.97 %
Day's Low: $ 51.06 30 Day Perf: -29.16 %
Volume (M): 344 52 Wk High: $ 79.99
Volume (M$): $ 17,795 52 Wk Avg: $59.98
Open: $52.46 52 Wk Low: $40.65



 Market Capitalization (Millions $) 833
 Shares Outstanding (Millions) 16
 Employees 10,400
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 161
 Cash Flow (TTM) (Millions $) 134
 Capital Exp. (TTM) (Millions $) 44

Piedmont Lithium Inc
Pall Corporation, incorporated in July 1946, and its subsidiaries is a leading supplier of fine filters, principally made by the Company using its proprietary filter media, and other fluid clarification and separations equipment for the removal of solid, liquid and gaseous contaminants from a wide variety of liquids and gases.

We serve customers in two principal markets: Life Sciences and Industrial. The two principal markets are further divided into five segments: Medical and BioPharmaceuticals (which comprise the Life Sciences business) and General Industrial, Aerospace and Microelectronics (which comprise the Industrial business).

We are a specialty materials and engineering company with the broadest-based filtration, separations and purification capabilities in the world. Our proprietary products are used to discover, develop and produce pharmaceuticals, produce safe drinking water, protect hospital patients, remove white blood cells from blood, enhance the quality and efficiency of manufacturing processes, keep equipment running efficiently and protect the environment. Requirements for product quality, purity, environmental preservation, health and safety apply to a wide range of industries and across geographic borders. We have a 57-year history of commercializing successful products and continue to develop new materials and technologies for the Life Sciences and Industrial markets and their increasingly difficult fluid filtration, purification and separation challenges. We have an array of core materials and technologies that can be combined and manipulated in many ways to solve complex fluid separation challenges. These proprietary materials, coupled with our ability to engineer them into useful forms, are the cornerstones of our capabilities. Our proprietary materials enable us to provide customers with products that are well matched to their needs, to develop new products and to enter new markets. With the addition of FSG, we enhanced our library of proprietary materials and technologies with sophisticated offerings such as asymmetric membranes, selective adsorption, melt-blown media, nano ceramic membranes and metallic fiber media.

We actively pursue only those applications in which Pall products can make a substantial difference to the customer and especially target projects that will result in real gains in performance and economics. The products sold are principally filters made with proprietary Pall filter media produced by chemical film casting, melt-blowing of polymer fibers, papermaking and metallurgical processes. Metal and plastic housings for our filters and a wide variety of appurtenant devices are also made. Competition is intense in all of our markets and includes many large and small companies in our global markets; however, no one company has a significant presence in all of our markets.

Most raw materials used by the Company are available from multiple sources. A limited number of materials are proprietary products of major chemical companies. The Company believes that it could find satisfactory substitutes for these materials should they become unavailable, as it has done several times in the past.

Our principal competitors in the Medical segment include Baxter, Asahi Medical, MacoPharma, Terumo and Fresenius, and our principal competitors in the BioPharmaceuticals segment include Millipore, Sartorius and CUNO.

Competition varies by product, and no single competitor competes with us across all sub-segments of Aerospace; however, our principal competitors include Donaldson, ESCO Technologies Inc. and CLARCOR.

The principal competitors in the Microelectronics market include Mykrolis and Mott.



   Company Address: 32 E Catawba Street Belmont 28012 NC
   Company Phone Number: 461-8000   Stock Exchange / Ticker: NASDAQ PLL
   PLL is expected to report next financial results on November 11, 2022.


Customers Net Income grew by PLL's Customers Net Profit Margin grew to

37.63 %

13.31 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
PNR   -3.07%    
GD   -0.68%    
TMO        4.25% 
RTX        0.8% 
MMM   -1.23%    
GE        2.27% 
• View Complete Report
   



Petrobras Petroleo Brasileiro Sa

Strong Double Digit EPS Growth, Sales Weak

In the financial interval ending Dec 31 2019 Petrobras Petroleo Brasileiro Sa profits soared by 41.82 % of $0.78 per share compared to $0.55 a year ago and from $0.00 per share from the previous quarter.

Cosan Ltd

Cosan Ltd declared financial period ending Dec 31 2019 operating surplus of $4496.934 millions

Cosan Ltd announced strong results in the financial period ending Dec 31 2019, where Sales rose by 22.37% to $20.61 billions and profits soared by 45.04 % to $5.55 per share, year on year.

Rada Electronic Industries Ltd

EPS Fell while Sales More than Doubled

Despite very strong Sales growth of 164.46% year on year to $117.24 millions in the fourth quarter of 2021 earnings season, company faced earnings turn positive at $0.50.

Sprott Physical Platinum and Palladium Trust

Break-even, Sales more than Doubled

Sprott Physical Platinum And Palladium Trust recorded operating loss of $-28.674627 millions, in the fiscal fourth quarter of 2019, a degradation from the operating shortfall of $-5.818561 millions, reported in fourth quarter of 2018

Bp Plc

Income Positive Again by Bp Plc in the fourth quarter of 2021 release

In the fourth quarter of 2021 Bp Plc earnings turn positive of $0.37 per share compared to $-1.00 a year ago and from $0.00 per share from the previous quarter.






 

Piedmont Lithium Inc 's Segments
 
Medical
 Segment    7.63 % of total Revenue
BioPharmaceuticals
 Segment    41.99 % of total Revenue
Total Life Sciences
 Segment    53.49 % of total Revenue
General Industrial
 Segment    19.67 % of total Revenue
Aerospace
 Segment    8.07 % of total Revenue
Microelectronics
 Segment    11.6 % of total Revenue
Total Industrial
 Segment    46.51 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Piedmont Lithium Inc does not provide revenue guidance.

Earnings Outlook
Bp Plc does not provide earnings estimates.

 
Geographic Revenue Dispersion
Americas 31.88 %
Europe 40.89 %
Asia 27.23 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GLBL's Profile

Stock Price

GLBL's Financials

Business Description

Fundamentals

Charts & Quotes

GLBL's News

Suppliers

GLBL's Competitors

Customers & Markets

Economic Indicators

GLBL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071